Literature DB >> 14585317

Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.

Mariana L dos Santos1, Alvaro S Sarkis, Inês N Nishimoto, Maria A Nagai.   

Abstract

Shorter CAG repeats in the androgen receptor (AR) gene have been associated with increased prostate cancer risk. Aiming to investigate whether the AR CAG polymorphism is associated with an increased relative risk for prostate cancer in our population, genomic DNA from 133 prostate cancer patients and 279 healthy men controls were examined. We found no association between the AR CAG polymorphism and the relative risk of prostate cancer in white Brazilian individuals with a CAG repeat length </=21. Our results show that in the studied population the Asian-descendants have the highest, the white an intermediate and the black a tendency to the lowest CAG repeats rates. We observed a significant correlation between a lower number of CAG repeats and young age at diagnosis (P=0.034). This study is the first to investigate the association between the AR CAG repeat polymorphism and the relative risk of prostate cancer in the Brazilian population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585317     DOI: 10.1016/s0361-090x(03)00106-5

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  8 in total

1.  The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis.

Authors:  Mingliang Gu; Xiaoqun Dong; Xuezhi Zhang; Wenquan Niu
Journal:  Mol Biol Rep       Date:  2011-06-12       Impact factor: 2.316

2.  Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancer.

Authors:  Xueying Mao; Jie Li; Xingxing Xu; Lara K Boyd; Weiyang He; Elzbieta Stankiewicz; Sakunthala C Kudahetti; Guangwen Cao; Daniel Berney; Guosheng Ren; Xin Gou; Hongwei Zhang; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

3.  Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.

Authors:  Douglas K Price; Cindy H Chau; Cathee Till; Phyllis J Goodman; Caitlin E Baum; Sandy B Ockers; Bevin C English; Lori Minasian; Howard L Parnes; Ann W Hsing; Juergen K V Reichardt; Ashraful Hoque; Catherine M Tangen; Alan R Kristal; Ian M Thompson; William D Figg
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

4.  Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study.

Authors:  Matthew L Freedman; Celeste L Pearce; Kathryn L Penney; Joel N Hirschhorn; Laurence N Kolonel; Brian E Henderson; David Altshuler
Journal:  Am J Hum Genet       Date:  2004-11-29       Impact factor: 11.025

5.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

Review 6.  Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer: A systematic review and meta-analysis.

Authors:  Zhiqiang Qin; Xiao Li; Peng Han; Yuxiao Zheng; Hanyu Liu; Jingyuan Tang; Chengdi Yang; Jianzhong Zhang; Kunpeng Wang; Xiaokang Qi; Min Tang; Wei Wang; Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

7.  Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.

Authors:  Hong Weng; Sheng Li; Jing-Yu Huang; Zi-Qi He; Xiang-Yu Meng; Yue Cao; Cheng Fang; Xian-Tao Zeng
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

8.  Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility.

Authors:  Calen P Ryan; Bernard J Crespi
Journal:  Evol Appl       Date:  2012-06-11       Impact factor: 5.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.